Item 2.02 Results of Operations and Financial Condition.

On August 2, 2012, Endocyte, Inc. (the "Company") announced its results of operations for the three and six months ended June 30, 2012. A copy of the Company's earnings release is furnished herewith as Exhibit 99.1.

The information in this Current Report (including Exhibit 99.1) is being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in this Current Report (including Exhibit 99.1) shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

99.1 Press Release dated August 2, 2012 relating to Endocyte's second quarter 2012 results of operations.

---

Top of the Form